Elan AIDS drug
Executive Summary
Irish firm to begin IND studies to evaluate EL 10 in HIV-infected subjects. First study of the oral copolymer adsorbate of DHEA is expected to begin shortly in San Francisco. A placebo-controlled trial is in progress in Amsterdam, and discussion with Canadian authorities have taken place regarding the initiation of two multicenter studies in that country early next year. Elan is developing the compound for AIDS under an exclusive license from Colthurst Ltd....